TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Agrenius Lungmedicin AB
Closing information (x1000 EUR)
| Closing information | 2023/06 | 2022/06 | 2021/06 |
| Turnover |
59
|
104
|
106 |
| Financial expenses |
4
|
0
|
0 |
| Earnings before taxes |
5
|
37
|
63 |
| EBITDA |
9
|
10
|
10 |
| Total assets |
275
|
343
|
361 |
| Current assets |
25
|
32
|
32 |
| Current liabilities |
15
|
29
|
33 |
| Equity capital |
246
|
293
|
303 |
| - share capital |
8
|
9
|
10 |
| Employees (average) |
1
|
1
|
1 |
Financial ratios
| Fiscal year | 2023/06 | 2022/06 | 2021/06 |
| Solvency |
89.5%
|
85.4%
|
83.9% |
| Turnover per employee |
59
|
104
|
106 |
| Profit as a percentage of turnover |
8.5%
|
35.6%
|
59.4% |
| Return on assets (ROA) |
3.3%
|
10.8%
|
17.5% |
| Current ratio |
166.7%
|
110.3%
|
97.0% |
| Return on equity (ROE) |
2.0%
|
12.6%
|
20.8% |
| Change turnover |
-36
|
3
|
-32 |
| Change turnover % |
-38%
|
3%
|
-23% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2023/06 | 2022/06 | 2021/06 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.